GB0505669D0 - Salts with CRTH2 antagonist activity - Google Patents

Salts with CRTH2 antagonist activity

Info

Publication number
GB0505669D0
GB0505669D0 GB0505669A GB0505669A GB0505669D0 GB 0505669 D0 GB0505669 D0 GB 0505669D0 GB 0505669 A GB0505669 A GB 0505669A GB 0505669 A GB0505669 A GB 0505669A GB 0505669 D0 GB0505669 D0 GB 0505669D0
Authority
GB
United Kingdom
Prior art keywords
salts
antagonist activity
crth2 antagonist
crth2
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0505669A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxagen Ltd
Original Assignee
Oxagen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxagen Ltd filed Critical Oxagen Ltd
Priority to GB0505669A priority Critical patent/GB0505669D0/en
Publication of GB0505669D0 publication Critical patent/GB0505669D0/en
Ceased legal-status Critical Current

Links

GB0505669A 2005-03-21 2005-03-21 Salts with CRTH2 antagonist activity Ceased GB0505669D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0505669A GB0505669D0 (en) 2005-03-21 2005-03-21 Salts with CRTH2 antagonist activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0505669A GB0505669D0 (en) 2005-03-21 2005-03-21 Salts with CRTH2 antagonist activity

Publications (1)

Publication Number Publication Date
GB0505669D0 true GB0505669D0 (en) 2005-04-27

Family

ID=34531526

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0505669A Ceased GB0505669D0 (en) 2005-03-21 2005-03-21 Salts with CRTH2 antagonist activity

Country Status (1)

Country Link
GB (1) GB0505669D0 (en)

Similar Documents

Publication Publication Date Title
GB0605743D0 (en) Salts with CRTH2 antagonist activity
HK1130256A1 (en) Compounds having crth2 antagonist activity
HK1145175A1 (en) Compounds having crth2 antagonist activity
ZA200804687B (en) Oxadiazole derivatives with CRTH2 receptor activity
GB0403635D0 (en) Pyridinocarboxamides with improved activity as kinase inhibitors
ATE489138T1 (en) SUBSTITUTED INDOLE COMPOUNDS WITH NOS INHIBITING ACTIVITY
ZA200803811B (en) Neuropolin antagonists
DK1854789T3 (en) QUINAZOLINE DERIVATIVES WITH TYROSIN-KINASE INHIBITORIC ACTIVITY
IL197714A0 (en) 2-pyridinecarboxamide derivative having gk-activating activity
HU0600809D0 (en) New phenylsulfamoil benzamide derivatives as bradykinin antagonists
IL199430A0 (en) Crth2 antagonists
HRP20130836T1 (en) New benzamide derivatives as bradykinin antagonists
ZA200800522B (en) New salt II
GB0500828D0 (en) Benzamide derivatives
ZA200900393B (en) Compounds having CRTH2 antagonist activity
GB0801674D0 (en) Compounds having CRTH2 antagonist activity
ZA200800515B (en) New Salt I
ZA200800488B (en) New Salt III
GB0505669D0 (en) Salts with CRTH2 antagonist activity
GB0526352D0 (en) Benzamide derivatives
EP1951694A4 (en) Salt forms
HRP20040318A2 (en) Furochromen derivative with anti-inflammaroty activity
GB0624176D0 (en) Compounds having CRTH2 antagonist activity
GB0801132D0 (en) Compounds having CRTH2 antagonist activity
GB0801671D0 (en) Compounds having crth2 antagonist activity

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)